LUKASZ SZARPAK to Precision Medicine
This is a "connection" page, showing publications LUKASZ SZARPAK has written about Precision Medicine.
Connection Strength
0.190
-
Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint. Cardiol J. 2025; 32(2):189-194.
Score: 0.190